Cargando…
Linear DNA amplicons as a novel cancer vaccine strategy
BACKGROUND: DNA-based vaccines represent a simple, safe and promising strategy for harnessing the immune system to fight infectious diseases as well as various forms of cancer and thus are considered an important tool in the cancer immunotherapy toolbox. Nonetheless, the manufacture of plasmid DNA v...
Autores principales: | Conforti, Antonella, Salvatori, Erika, Lione, Lucia, Compagnone, Mirco, Pinto, Eleonora, Shorrock, Clay, Hayward, James A., Sun, Yuhua, Liang, Ben Minghwa, Palombo, Fabio, Viscount, Brian, Aurisicchio, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169303/ https://www.ncbi.nlm.nih.gov/pubmed/35668533 http://dx.doi.org/10.1186/s13046-022-02402-5 |
Ejemplares similares
-
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
por: Conforti, Antonella, et al.
Publicado: (2023) -
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
por: Salvatori, Erika, et al.
Publicado: (2022) -
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets
por: Martins, Mathias, et al.
Publicado: (2023) -
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
por: D’Alessio, Federico, et al.
Publicado: (2023) -
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
por: Lione, Lucia, et al.
Publicado: (2021)